Diaceutics (LON:DXRX) Releases Earnings Results

Diaceutics (LON:DXRX) issued its quarterly earnings results on Tuesday. The company reported GBX 11 earnings per share for the quarter, Digital Look Earnings reports. Diaceutics had a negative return on equity of 3.94% and a negative net margin of 4.42%.The business had revenue of GBX 3,844 million for the quarter.

Diaceutics Price Performance

Shares of DXRX stock opened at GBX 152.04 on Wednesday. Diaceutics has a fifty-two week low of GBX 112.25 and a fifty-two week high of GBX 180. The firm has a market capitalization of £128.67 million, a price-to-earnings ratio of -84.47 and a beta of 0.92. The company has a debt-to-equity ratio of 3.05, a quick ratio of 9.92 and a current ratio of 3.96. The stock’s 50-day simple moving average is GBX 161.36 and its 200-day simple moving average is GBX 154.45.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.